CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- 4 Exercise or conversion Director acquired 1,300 shares (option exercise)
- 4 Planned sale CHIEF LEGAL OFFICER sold 12,500 shares at an average $39.40 ($492,461)
- 4 Planned sale Chief Medical Officer sold 2,220 shares at $38.93 ($86,425)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 12,220 shares at an average $39.91 ($487,725)
- 4 Planned sale Chief Medical Officer sold 2,000 shares at $40.00 ($80,000)
- 4 Open-market buy 10% owner bought 273,972 shares at $36.50 ($9,999,978)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Medical Officer sold 1,500 shares at $35.00 ($52,500)
- 4 Planned sale Director sold 10,000 shares at an average $30.64 ($306,422)
- 4 Planned sale Director sold 1,950 shares at $23.17 ($45,182)
- 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,900 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,035 shares (option exercise)
- 4 Open-market sale Director sold 1,950 shares at $23.16 ($45,162)
- 4 Exercise or conversion Director acquired 4,534 shares (option exercise)
Page 5 of 15 · 298 filings